Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

trials

J&J expands corona vaccine clinical trials for children, newborns, and pregnant women

J&J expands corona vaccine clinical trials for children, newborns, and pregnant women

[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment

[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment

[국제]Corona vaccine clinical trials for children begin…

[국제]Corona vaccine clinical trials for children begin…

Hanallbio ceases clinical trials for technology exports of 500 million yen to the US

Hanallbio ceases clinical trials for technology exports of 500 million yen to the US

Investment decision in Genencell, which is undergoing corona clinical trials in Pharma Korea

Investment decision in Genencell, which is undergoing corona clinical trials in Pharma Korea

Daewoong’s’Hoystar tablet’ accelerates clinical trials for COVID-19

Daewoong’s’Hoystar tablet’ accelerates clinical trials for COVID-19

Daewoong Pharmaceutical’s’Hoystar tablet’ approved for phase 3 clinical trials for COVID-19 prevention effect

Daewoong Pharmaceutical’s’Hoystar tablet’ approved for phase 3 clinical trials for COVID-19 prevention effect

Modena and Takeda Pharm start phase 1 and 2 clinical trials of COVID-19 vaccine in Japan

Modena and Takeda Pharm start phase 1 and 2 clinical trials of COVID-19 vaccine in Japan

Hanmi Pharm received FDA approval for Phase 2 clinical trials of two new drug candidates for rare diseases

Hanmi Pharm received FDA approval for Phase 2 clinical trials of two new drug candidates for rare diseases

Hanmi Pharm approves Phase 2 clinical trials for two innovative new drugs for rare disease treatment

Hanmi Pharm approves Phase 2 clinical trials for two innovative new drugs for rare disease treatment

The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical

The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical

UBiologics begins clinical trials for COVID-19 vaccine

UBiologics begins clinical trials for COVID-19 vaccine

Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en